MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 2221 to 2240 of 166,322 approvalsPage 112 of 8317

Aciclovir Tablets

Approval Number: 国药准字H20247303
Registration: Dec 12, 2024

Granisetron Hydrochloride Injection

Approval Number: 国药准字H20247313
Registration: Dec 11, 2024

Trilaciclib Hydrochloride for Injection

Approval Number: 国药准字H20247315
Registration: Dec 11, 2024

Cefmetazole Sodium for Injection

Approval Number: 国药准字H20247311
Registration: Dec 11, 2024

Fudosteine Oral Solution

Approval Number: 国药准字H20247310
Registration: Dec 11, 2024

Desloratadine Oral Solution

Approval Number: 国药准字H20247314
Registration: Dec 11, 2024

Cefmetazole Sodium for Injection

Approval Number: 国药准字H20247312
Registration: Dec 11, 2024

Valsartan and Amlodipine Tablets(I)

Approval Number: 国药准字H20249724
Registration: Dec 10, 2024

Phenylephrine Hydrochloride Injection

Approval Number: 国药准字H20249727
Registration: Dec 10, 2024

Lodoxamide Tromethamine Eye Drops

Approval Number: 国药准字H20249725
Registration: Dec 10, 2024

Selexipag Tablets

Approval Number: 国药准字H20249717
Registration: Dec 10, 2024

Selexipag Tablets

Approval Number: 国药准字H20249719
Registration: Dec 10, 2024

Bupivacaine Hydrochloride Injection

Approval Number: 国药准字H20247309
Registration: Dec 10, 2024

Rocuronium Bromide Injection

Approval Number: 国药准字H20249722
Registration: Dec 10, 2024

Rocuronium Bromide Injection

Approval Number: 国药准字H20249723
Registration: Dec 10, 2024

Selexipag Tablets

Approval Number: 国药准字H20249720
Registration: Dec 10, 2024

Bumetanide Injection

Approval Number: 国药准字H20249728
Registration: Dec 10, 2024

Selexipag Tablets

Approval Number: 国药准字H20249718
Registration: Dec 10, 2024

Phenylephrine Hydrochloride Injection

Approval Number: 国药准字H20249726
Registration: Dec 10, 2024

Selexipag Tablets

Approval Number: 国药准字H20249721
Registration: Dec 10, 2024

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.